Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576003 · ClinicalTrials.gov registry record · NA
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01576003 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 10 participants.
The verdict
NCT01576003, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy) will work better by preventing bloodstream infections, improving growth, and/or changing the make-up of bacteria in your child's intestine. Glutamine is approved by the FDA for use in adults with Short Bowel Syndrome. In this study, the investigators will be assessing how well Glutamine affects Short Bowel Syndrome in children.
Interventions
- DRUG Glutamine
- DIETARY_SUPPLEMENT L-alanine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01576003
The ClinicalTrials.gov registry entry for NCT01576003 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Glutamine is the first listed.
NCT01576003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01576003 about?
NCT01576003 is a clinical study titled "Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants". The purpose of this research study is to evaluate the effects (good and bad) of supplementation with Glutamine to that of a placebo (L-alanine), on your child and their Short Bowel Syndrome. Researchers are doing this study to see if the addition of Glutamine to oral/tube feeding (nutrition therapy)...
What is the current status of trial NCT01576003?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2012-04. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01576003?
The interventions under investigation include: Glutamine (DRUG), L-alanine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01576003?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.